BPC-157 | 20mg | 3ml

BPC-157 is a synthetic pentadecapeptide — a fifteen-amino-acid chain whose sequence corresponds to a partial fragment of a protein identified in gastric juice. It is written BPC-157, BPC157, or "body protection compound 157". The molecule is well defined; what differs between vendors is purity, format, and whether the documentation can be traced to your specific vial.

Research use only. Supplied strictly for in-vitro laboratory research. This page covers composition, chemistry, format, quality documentation and storage. It does not describe dosing, administration, or use in humans or animals, and makes no therapeutic claims.

Composition and what ships

Fifteen residues, supplied pre-mixed as a solution at 20mg per vial, sealed, cold-packed, with a batch Certificate of Analysis. Synthesized in our UK laboratory; each US batch is verified in a US laboratory before release.

Because BPC-157 is a short, unmodified peptide with no unusual residues, it is straightforward to synthesize well — and equally straightforward to synthesize badly and sell anyway. Purity is where the difference shows, and purity is only meaningful as an HPLC figure attached to a named batch.

Solution versus lyophilized powder, for a US laboratory

The default in the US market is lyophilized powder. The comparison that actually matters:

Neither format is superior in the abstract. A solution suits work where the concentration must be known and identical between vials without a preparation step; a powder suits long storage and labs that reconstitute routinely. Choose against your protocol, not against a marketing line.

BPC-157 and TB-500 are not interchangeable

These two are frequently listed side by side and are chemically unrelated. BPC-157 is a fifteen-residue sequence derived from a gastric protein. TB-500 is a synthetic fragment of thymosin beta-4, a distinct actin-binding protein. They appear together in blends — our Wolverine stack pairs them — but a study design that names one is not satisfied by the other. If a supplier's copy treats them as substitutes, that tells you something about the copy.

There is no oral BPC-157

Capsules and oral preparations marketed under this name are common online. As a peptide of this length, BPC-157 is not stable through gastric conditions in any form that survives as the intact fifteen-residue chain. We supply a solution for laboratory research and make no claim about any route of administration, because we do not describe administration at all.

Documentation

Every vial carries a batch number tied to a COA published in our COA library. The document states the HPLC purity figure and the method used, and mass spectrometry consistent with the expected mass. If you cannot match a lot number on a vial to a document, you do not have documentation — you have a brochure.

Storage

Refrigerate at 2–8°C on arrival, keep sealed and out of light, do not freeze the solution format. Log the lot number before discarding the outer packaging.

A note on competition testing

BPC-157 appears on the World Anti-Doping Agency prohibited list. This is stated as a fact relevant to anyone whose institution or subjects fall under anti-doping rules; it is not guidance, and it does not change that this material is supplied for in-vitro laboratory research only.